Status:
COMPLETED
The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
Lead Sponsor:
Mayo Clinic
Conditions:
Liver Transplant Recipients
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This research study is being done to study the effects, both good and bad, of calcineurin inhibitors and the drug Cozaar (losartan), on kidney function and kidney scarring following a liver transplant...
Detailed Description
This study is a double-blinded, placebo controlled trial to help determine the pathogenesis of chronic renal dysfunction in patients undergoing liver transplantation. It will examine the renal functio...
Eligibility Criteria
Inclusion
- Participants who will be undergoing a liver transplant and are between the ages of 18 to 70 years of age.
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2007
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00275639
Start Date
December 1 2004
End Date
August 1 2007
Last Update
January 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905